Atazanavir sulfate
Code | Size | Price |
---|
TAR-T0100-5mg | 5mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-1mL | 1 mL * 10 mM (in DMSO) | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-10mg | 10mg | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-25mg | 25mg | £149.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-50mg | 50mg | £172.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-100mg | 100mg | £244.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0100-200mg | 200mg | £331.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Atazanavir sulfate is an azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.
CAS:
229975-97-7
Formula:
C38H52N6O7?H2SO4
Molecular Weight:
802.93
Pathway:
Metabolism; Proteases/Proteasome; Microbiology/Virology; Membrane transporter/Ion channel; Neuroscience
Purity:
0.9967
SMILES:
S(=O)(=O)(O)O.O=C(N[C@H]([C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc1ccc(c2ncccc2)cc1)Cc1ccccc1)[C@@H](NC(=O)OC)C(C)(C)C
Target:
P45; SARS-CoV; HIV Protease; P-gp
References
1. Robinson BS, et al. Antimicrob Agents Chemother, 2000, 44(8), 2093-2099.
2. Zhang D, et al. Drug Metab Dispos, 2005, 33(11), 1729-1739.
3. Pyrko P, et al. Cancer Res, 2007, 67(22), 10920-10928.
4. Parker RA, et al. Mol Pharmacol, 2005, 67(6), 1909-1919.
5. Perloff ES, et al. Drug Metab Dispos, 2005, 33(6), 764-770.